DNA Testing Market Analysis By Technology (DNA Diagnostics, Microarray Based, PCR Based, In-situ Hybridization, NGS DNA Diagnosis), By Application (Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics (HBV, HCV, HIV, TB, CT/NG, HPV, & MRSA), Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, Pharmacogenomics Diagnostic Testing, & Drug Metabolism/P450 Effects), And Segment Forecasts To 2022

Published: Jan, 2016 | Pages: 85 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

Global DNA testing market is anticipated to reach USD 10.04 billion by 2022, according to a new study by Grand View Research Inc. Rise in developments in the field of genome sequencing and personalized DNA level diagnostic applications, a considerable growth in the number of patented research initiatives by the government and government funded projects are factors expected to drive demand during the forecast period.

Introduction of novel technologies for genome profiling are expected to boost progress of this industry over the forecast period. Furthermore, increasing incidences of chronic oncology and infectious diseases that depend on DNA prototyping for treatment and diagnosis using personalized medicine are anticipated to significantly raise demand for DNA diagnostics/testing based research thereby propelling industrial growth in the coming years. Increasing demand for prenatal testing and in-vitro fertilization that subsequently leads to rise in demand for DNA diagnostics/testing is also attributive towards expected progress in this market.

Further key findings from the study suggest:

PCR based diagnosis accounted for the largest share of the market revenue in 2014 as a result of higher preference rate coupled with higher availability of products and reagent kits of this segment.

Next generation sequencing application for DNA testing is estimated to witness significant progress with a double digit CAGR of over 16% amongst the other technology segments due to presence of significant advantages offered by this technique of DNA identification and testing.

Infectious disease diagnostics accounted for the largest market share in 2014 due to higher incidence rate of various infectious disorders which subsequently raises the demand for in-vitro nucleic acid based diagnostic tests for diagnosis and monitoring of disease progression.

There are diverse applications of DNA testing market out of which oncology diagnostics and histopathology is estimated to register lucrative growth over the forecast period. Factors attributing for considerable growth potential in this segment include identification of cancer causing genes & associated research, and facilitation in mutation detection

North America dominated the market in 2014, with revenue estimated at over USD 2,600 million. Presence of sophisticated healthcare infrastructure, rising incidence of genetic abnormalities, favorable government initiatives with respect to genetic diagnosis and its application in in-vitro fertilization are major factors driving growth of this region.

Asia Pacific is anticipated to witness lucrative growth as a result of developments in health care infrastructure in this region coupled with presence of significant number of target population that is suffering with chronic as well as acute disorders. Government initiatives taken up herein are also attributive to influence sector growth to a great extent.

Key participants of DNA testing industry include Abbott Laboratories, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Applied Biosystems Group, Cepheid Inc., Transgenomic Inc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Alere Inc, Affymetrix Inc., Hologic, Dako, and 454 Life Sciences.

 Table of Content

Chapter 1. Methodology and Scope
               1.1. Research Methodology
               1.2. Research Scope & Assumptions
               1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. DNA Diagnostics/Testing Industry Outlook
               3.1. Market Segmentation
               3.2. Market Size and Growth Prospects
                  3.2.1. Market Driver Analysis
                  3.2.2. Market Restraint Analysis
               3.3. DNA Diagnostics/Testing Market Dynamics
               3.4. Key Opportunities Prioritized Technology Based
                              3.5. Key Opportunities Prioritized Application Based
               3.6. Technology Positioning, 2014
                  3.6.1. Accuracy /Dynamic range
                  3.6.2. Price / cost per sample
                  3.6.3. Availability
                  3.6.4. Complexity
                  3.6.5. Technological advancements
                  3.6.6. Applications
                  3.6.7. Time consumption
               3.7. Competitive Landscape for Companies, 2014 (Subject to data availability)
               3.8. Industry Analysis -Porter's
               3.9. DNA Diagnostics/Testing Market PESTEL Analysis
Chapter 4. DNA Diagnostics/Testing Technology Outlook
               4.1. PCR Based Diagnostics
                  4.1.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               4.2. NGS DNA Diagnosis
                  4.2.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               4.3. In-situ Hybridization Diagnostics
                  4.3.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               4.4. Micro-arrays Based Diagnostics
                  4.4.1. Market Estimates and Forecasts, 2012 - 2022(USD Million)
Chapter 5. DNA Diagnostics/Testing Application Outlook
               5.1. Pre-natal DNA Carrier Screening
                  5.1.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.2. Pre-implantation Diagnosis
                  5.2.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.3. New-born Genetic Screening
                  5.3.1. Market Estimates and Forecasts, 2012 - 2022(USD Million)
               5.4. Infectious Disease Diagnostics
                  5.4.1. Infectious Diseases Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.2. HBV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.2.1. HBV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.3. HCV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.3.1. HCV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.4. HIV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.4.1. HIV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.5. TB Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.5.1. TB Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.6. CT/NG Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.6.1. CT/NG Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.7. HPV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.7.1. HPV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.8. MRSA Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.8.1. MRSA Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.9. Other Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.9.1. Other Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.5. Oncology Diagnostics & Histopathology
                  5.5.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.6. Identity Diagnostics & Forensics
                  5.6.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.7. Pharmacogenomics Diagnostic Testing
                  5.7.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.8. Drug Metabolism & P450 Effects
                  5.8.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.9. Others
                  5.9.1. Others Market Estimates and Forecasts, 2012 - 2022 (USD Million)
Chapter 6. DNA Diagnostics/Testing Regional Outlook (Revenue, USD Million, 2012 - 2022)
               6.1. North America
                  6.1.1. U.S.
                        6.1.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.1.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
                  6.1.2. Canada
                        6.1.2.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.1.2.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
               6.2. Europe
                  6.2.1. Germany
                        6.2.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.2.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
                  6.2.2. UK
                        6.2.2.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.2.2.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
               6.3. Asia Pacific
                  6.3.1. China
                        6.3.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.3.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
                  6.3.2. Japan
                        6.3.2.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.3.2.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
               6.4. Latin America
                  6.4.1. Brazil
                        6.4.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.4.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
               6.5. MEA
                  6.5.1. South Africa
                        6.5.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.5.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
Chapter 7. Competitive Landscape
               7.1. 454 Life Sciences
                  7.1.1. Company Overview
                  7.1.2. Revenue Analysis
                  7.1.3. Product Benchmarking
                  7.1.4. Strategic Development
               7.2. Abbott Laboratories
                  7.2.1. Company Overview
                  7.2.2. Revenue Analysis
                  7.2.3. Product Benchmarking
                  7.2.4. Strategic Development
               7.3. Affymetrix Inc.
                  7.3.1. Company Overview
                  7.3.2. Revenue Analysis
                  7.3.3. Product Benchmarking
                  7.3.4. Strategic Development
               7.4. Agilent Technologies Inc.
                  7.4.1. Company Overview
                  7.4.2. Revenue Analysis
                  7.4.3. Product Benchmarking
                  7.4.4. Strategic Development
               7.5. Applied Biosystems Group
                  7.5.1. Company Overview
                  7.5.2. Revenue Analysis
                  7.5.3. Product Benchmarking
                  7.5.4. Strategic Development
               7.6. Thermo Fisher Scientific Inc.
                  7.6.1. Company Overview
                  7.6.2. Revenue Analysis
                  7.6.3. Product Benchmarking
                  7.6.4. Strategic Development
               7.7. Illumina Inc.
                  7.7.1. Company Overview
                  7.7.2. Revenue Analysis
                  7.7.3. Product Benchmarking
                  7.7.4. Strategic Development
               7.8. Cepheid Inc.
                  7.8.1. Company Overview
                  7.8.2. Revenue Analysis
                  7.8.3. Product Benchmarking
                  7.8.4. Strategic Development
               7.9. Hologic
                  7.9.1. Company Overview
                  7.9.2. Revenue Analysis
                  7.9.3. Product Benchmarking
                  7.9.4. Strategic Development
               7.10. Bio-Rad Laboratories
                  7.10.1. Company Overview
                  7.10.2. Revenue Analysis
                  7.10.3. Product Benchmarking
                  7.10.4. Strategic Development
               7.11. Dako
                  7.11.1. Company Overview
                  7.11.2. Revenue Analysis
                  7.11.3. Product Benchmarking
                  7.11.4. Strategic Development
               7.12. Alere Inc.
                  7.12.1. Company Overview
                  7.12.2. Revenue Analysis
                  7.12.3. Product Benchmarking
                  7.12.4. Strategic Development
               7.13. Roche Diagnostics
                  7.13.1. Company Overview
                  7.13.2. Revenue Analysis
                  7.13.3. Product Benchmarking
                  7.13.4. Strategic Development
               7.14. Beckman Coulter Inc.
                  7.14.1. Company Overview
                  7.14.2. Revenue Analysis
                  7.14.3. Product Benchmarking
                  7.14.4. Strategic Development
               7.15. Siemens Healthcare
                  7.15.1. Company Overview
                  7.15.2. Revenue Analysis
                  7.15.3. Product Benchmarking
                  7.15.4. Strategic Development

List of Tables

1. DNA diagnostics/testing market - Industry Snapshot & Key Buying Criteria, 2012 - 2022
2. Global DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
3. Global DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
4. Global DNA diagnostics/testing market, by region, 2012 - 2022 (USD Million)
5. DNA diagnostics/testing- Key market driver analysis
6. DNA diagnostics/testing- Key market restraint analysis
7. Rating scale for product positioning
8. Competitive landscape of companies, 2014
9. North America DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
10. North America DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
11. North America DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
12. U.S. DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
13. U.S. DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
14. U.S. DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
15. Canada DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
16. Canada DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
17. Canada DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
18. Europe DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
19. Europe DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
20. Europe DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
21. Germany DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
22. Germany DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
23. Germany DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
24. UK DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
25. UK DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
26. UK DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
27. Asia Pacific DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
28. Asia Pacific DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
29. Asia Pacific DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
30. Japan DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
31. Japan DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
32. Japan DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
33. China DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
34. China DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
35. China DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
36. Latin America DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
37. Latin America DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
38. Latin America DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
39. Brazil DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
40. Brazil DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
41. Brazil DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
42. Mexico DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
43. Mexico DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
44. Mexico DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
45. MEA DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
46. MEA DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
47. MEA DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
48. South Africa DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
49. South Africa DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
50. South Africa DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)